Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retroviruses02:33

Retroviruses

12.3K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.3K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

C1q and immunoglobulins mediate activity-dependent synapse loss in the adult brain.

Science (New York, N.Y.)·2026
Same author

Population Pharmacokinetic Modeling and Simulation to Support the Regulatory Submission of the Two-Injection Start Regimen with Aripiprazole Once-Monthly Long-Acting Injectable Intramuscular Administration in Japanese Patients with Schizophrenia or Bipolar I Disorder.

Journal of clinical pharmacology·2026
Same author

VPS13C/PARK23 initiates lipid transfer and membrane remodeling for efficient lysosomal repair.

Nature communications·2026
Same author

Combinatorial analysis of clinical and genomic data used to assess the association between SARS-CoV-2 mutations and disease severity.

PNAS nexus·2026
Same author

Effects of Ripasudil on Mouse Subconjunctival Immune Cell Motility Activated by Monocyte Chemoattractant Protein-1.

Investigative ophthalmology & visual science·2026
Same author

Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activity.

Science advances·2026

Related Experiment Video

Updated: Jun 30, 2025

Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy
13:08

Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy

Published on: October 7, 2010

16.6K

HIV-Tocky system to visualize proviral expression dynamics.

Omnia Reda1,2, Kazuaki Monde3, Kenji Sugata1

  • 1Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.

Communications Biology
|March 21, 2024
PubMed
Summary

Understanding human immunodeficiency virus type 1 (HIV-1) latency is crucial. A new HIV reporter model, HIV-Tocky, distinguishes directly latent and recently silenced cells, offering insights into HIV reservoirs.

More Related Videos

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

5.8K
Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

12.1K

Related Experiment Videos

Last Updated: Jun 30, 2025

Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy
13:08

Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy

Published on: October 7, 2010

16.6K
High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

5.8K
Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

12.1K

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • HIV-1 latency establishment remains poorly understood.
  • The HIV reservoir consists of infected cells evading immune and viral clearance.
  • Existing in vitro models have limitations in analyzing provirus silencing dynamics.

Purpose of the Study:

  • To introduce a novel HIV reporter model, HIV-Timer of cell kinetics and activity (HIV-Tocky).
  • To enable the dissection of provirus silencing and reactivation dynamics.
  • To characterize distinct latent HIV populations.

Main Methods:

  • Development of the HIV-Tocky reporter model with dual fluorescence.
  • Utilizing spontaneous fluorescence shifting to track provirus silencing.
  • Analyzing integration features of latent cell populations.

Main Results:

  • HIV-Tocky can reveal provirus silencing and reactivation dynamics.
  • Identification of two distinct latent populations: directly latent and recently silenced.
  • The recently silenced subset exhibits integration characteristics indicative of stable latency.

Conclusions:

  • The HIV-Tocky model provides a novel tool for studying HIV latency.
  • It addresses the heterogeneous nature of HIV reservoirs.
  • Offers new avenues for evaluating HIV eradication strategies.